Tag: Healthcare Innovation
EU HTA Is Changing European Market Access: Why Early Evidence Planning Is Now Essential
EU HTA Is Changing European Market Access: Why Early Evidence Planning Is Now Essential The European pharmaceutical industry is entering a new era. With the implementation of the European Union Health Technology Assessment (EU HTA) Regulation, companies must rethink how they generate clinical evidence, align cross-functional teams, and prepare for successful market access across Europe.…
Why Pharma Companies Should Stress-Test Their Market Access Strategy Before EU HTA Submission
Why Pharma Companies Should Stress-Test Their Market Access Strategy Before EU HTA Submission How pre-submission evidence reviews are becoming the next competitive advantage for pharmaceutical and biotech companies in Europe. The pharmaceutical industry has entered a new era of evidence generation. For years, achieving regulatory approval was considered the biggest milestone on the path to…
Regulatory-Grade AI and Living Evidence
Why Regulatory-Grade AI & Living Evidence Are Replacing Traditional RWE Models in Pharma A Turning Point for Real-World Evidence in Pharma Real-World Evidence (RWE) has become a cornerstone of pharmaceutical decision-making. Regulators, HTA bodies, and payers increasingly rely on RWE to support approvals, reimbursement decisions, and post-market monitoring. However, as expectations rise, traditional RWE models…
Why Global Health Agencies Are Demanding RWE in 2025
Why Global Health Agencies Are Demanding Real-World Evidence in 2025 And What It Means for Market Access In 2025, healthcare is no longer defined by clinical trial results alone. Across the globe, regulatory bodies and health technology assessment (HTA) agencies are making one thing crystal clear: Real-World Evidence (RWE) is now a non-negotiable requirement for…
The Must-Attend Event of the Year 2025
Why the Global RWE & Market Access Summit 2025 is the Must-Attend Event of the Year What is the Global RWE & Market Access Summit? The Global RWE (Real-World Evidence) and Market Access Summit 2025, set to take place from October 15th-16th in Frankfurt, Germany, is a premier event uniting thought leaders, industry experts, and…
